This most current twist during the Lykos Therapeutics saga threatens A serious overhaul of the corporate’s approach and path, with Musk ally and billionaire Trader Antonio Gracias showing to need to consider the company again towards its nonprofit drug enhancement roots and a more Doblinite philosophy.In many respects, the for-earnings copyright